Clinical update

Ovarian cancer and Olaparib: what nurses need to know

Olaparib has won NICE approval as a first-line maintenance treatment for ovarian cancer rather than waiting after further rounds of chemotherapy
Posted 21 August 2019 - 10:00
Picture shows olaparib capsules. Olaparib inhibits enzymes that repair DNA in cancer cells.
 
Jobs

Related articles

Systemic anticancer therapy service redesign

A project is addressing demand for SACT and testing changes such as outreach service delivery
19 Mar 2024

How you can help cancer patients cope with anxiety over treatment and its side effects

Nurses play a crucial role in providing reassurance through support and personalised care
05 Mar 2024

Patient concerns after haematopoietic stem cell transplantation: an evaluation

Importance of holistic assessment of needs post-HSCT and a care plan promoting recovery
14 Feb 2024

Breast cancer: boost to specialist nurse numbers could slash costs

Investment in cancer nurse specialists could save NHS up to £118 million
23 Jan 2024
5 Most Read Articles

A guide to managing your finances: how to save money and access support

Four experts offer their top tips for nurses on tax, pensions, debt and grants
02 Feb 2024

Duty of care: the legal, ethical and professional points to consider

What duty of care means for you, whether at work, off-duty or on strike
07 Mar 2023

A specialty in crisis

Around half of diabetes specialist nurses are expected to retire in the next decade, and one...
09 Sep 2015

Active listening: what is it and how can I use it effectively?

Tips on honing your communication skills to improve outcomes
27 Jun 2023

Becoming a nurse prescriber: how it could take your career in unexpected directions

Find out what you need to do to be qualified to practise as a non-medical prescriber
21 Oct 2021
Journals
Other RCNi websites